News

SpeeDx eyes compliance testing markets adding saliva claim to PlexPCR SARS-CoV-2 diagnostic in Europe SpeeDx Expand COVID-19 Diagnostics to Include Self-Collected Samples ...
SpeeDx continues to expand their SARS-CoV-2 Genotyping reagent portfolio with key mutations to target existing and emerging variants of concern.
PERTH, Australia – Molecular diagnostic company Speedx Pty Ltd. has invested in a Perth-based startup that makes the raw materials needed for polymerase chain reaction (PCR) COVID-19 tests. The two ...